2024. Bimekizumab Efficacy by Prior Biologic Treatment in Patients with Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s349. DOI:https://doi.org/10.25251/skin.8.supp.349.